April 3, 2013 / 12:22 PM / 4 years ago

Valeant sweetens bid for Obagi Medical

April 3 (Reuters) - Valeant Pharmaceuticals International Inc raised its offer for cosmetics products maker Obagi Medical Products Inc to $24 per share, a day after its initial bid was topped by German drugmaker Merz Pharma Group.

Obagi and Valeant agreed to a deal last month in which Valeant offered $19.75 per share. However, Merz Pharma topped that with an offer of $22 per share.

Canada’s Valeant said its latest offer, which values Obagi at about $418 million, has been approved by Obagi’s board.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below